Your session is about to expire
← Back to Search
Long-acting PrEP Injections + Adherence App for HIV Prevention in Transgender Women
Study Summary
This trial will test if transgender women (TW) can use tailored injection strategies, such as self-injection or injection by a healthcare provider at "drop-in clinics", to improve adherence to HIV prevention medication, compared to a control group of TW.
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- You have a smartphone that can download and use apps.
- Group 1: Injection by HCP at "drop-in" clinics
- Group 2: Self-injection
- Group 3: Control group
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Does this research include elderly participants?
"In order to qualify for this clinical trial, applicants must be between 18 and 100. Those who are younger than 18 or older than 65 may still consider one of the 6 trials that cater exclusively to those age brackets."
To what extent has enrollment been successful for this experiment?
"Affirmative. According to clinicaltrials.gov, this scientific research was initially posted on October 23rd 2020 and is currently recruiting participants. The trial requires 45 patients from one site for completion."
For which patient population is this study most suitable?
"To be considered for inclusion in this trial, applicants must have a HIV diagnosis and fall in the age range of 18 to 100. The study is looking for 45 participants."
Are there any available spots for participants in this trial?
"This clinical trial, which was initially publicized on October 23rd 2020 is actively recruiting participants. The study has been recently updated as of November 2nd 2022 and can be found online."
Who else is applying?
What state do they live in?
How old are they?
What portion of applicants met pre-screening criteria?
Share this study with friends
Copy Link
Messenger